-
Facebook
-
Twitter
-
Google +1
Request a feature- LooksNeat © 2025. All Rights Reserved
- Terms of Service
- Privacy Policy
- Cookies
- Developed by My Guy Solutions, LLC
Democrats staring down a divided Congress in 2023 have an answer for those wondering if the window is closing for significant health care wins: watch and wait.
The incoming GOP House majority may block their attempts to enact more federal controls on health costs. But this year’s passage of the Inflation Reduction Act will empower Medicare to negotiate drug prices for the first time, paving the way for moregovernment action over the coming years, argued Peter Welch (D-Vt.).
“The...